Evidence map›Paper›PMID 24943221›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Metabolic engineering of Salmonella vaccine bacteria to boost human Vγ2Vδ2 T cell immunity.

Grefachew Workalemahu, Hong Wang, Kia-Joo Puan, Mohanad H Nada, Tomohisa Kuzuyama, Bradley D Jones, Chenggang Jin, Craig T Morita

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.7field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Resistance-resistant antibiotics.Trends in pharmacological sciences · 2014
    Review
  16. Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Grefachew WorkalemahuDivision of Immunology, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52242; Department of Veterans Affairs, Iowa City Health Care System, Iowa City, IA 52246;
Hong WangDivision of Immunology, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52242; Department of Veterans Affairs, Iowa City Health Care System, Iowa City, IA 52246;
Kia-Joo PuanDivision of Immunology, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52242; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648;
Mohanad H NadaDivision of Immunology, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52242; Department of Veterans Affairs, Iowa City Health Care System, Iowa City, IA 52246; Interdisciplinary Graduate Program in Immunology, University of Iowa Carver College of Medicine, Iowa City, IA 52242;
Tomohisa KuzuyamaBiotechnology Research Center, The University of Tokyo, Tokyo 113-8657, Japan;
Bradley D JonesDepartment of Microbiology, University of Iowa Carver College of Medicine, Iowa City, IA 52242; Interdisciplinary Graduate Program in Genetics, University of Iowa Carver College of Medicine, Iowa City, IA 52242; and Inflammation Program, University of Iowa Carver College of Medicine, Iowa City, IA 52242.
Chenggang JinDivision of Immunology, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52242; Department of Veterans Affairs, Iowa City Health Care System, Iowa City, IA 52246;
Craig T MoritaDivision of Immunology, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52242; Department of Veterans Affairs, Iowa City Health Care System, Iowa City, IA 52246; Interdisciplinary Graduate Program in Immunology, University of Iowa Carver College of Medicine, Iowa City, IA 52242; Craig-Morita@uiowa.edu.
University of Iowa · USIowa City VA Health Care System · USThe University of Tokyo · JP

Funding

Virology and Smallpox VaccinationsU54AI057160 · NIAID · WASHINGTON UNIVERSITY · PI RAY, RANJIT · 2003 to 2013
$80.9M
Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Douglas Robert Spitz · 2000 to 2026
$70.0M
The Role of Monocytes in non-Hodgkin LymphomaP50CA097274 · NCI · UNIVERSITY OF IOWA · PI WEINER, GEORGE J. · 2002 to 2021
$45.7M
Studies of the capsular-like antigen of F. tularensisP01AI044642 · NIAID · UNIVERSITY OF IOWA · PI NAUSEEF, WILLIAM M. · 1999 to 2014
$18.2M
PREDOCTORAL TRAINING PROGRAM IN IMMUNOLOGYT32AI007485 · NIAID · UNIVERSITY OF IOWA · PI Kevin L Legge · 1995 to 2026
$5.4M
Human neutrophils, phospholipase A2 and S.aureus: microbial targets and responsesI01BX000513 · VA · IOWA CITY VA MEDICAL CENTER · PI NAUSEEF, WILLIAM M. · 2009 to 2017
–
Metabolic Engineering of Bacteria for Cancer Immunotherapy by Gamma Delta T CellsI01BX000972 · VA · IOWA CITY VA MEDICAL CENTER · PI MORITA, CRAIG T · 2012 to 2023
–
BLRD VA I01 BX000513BLRD VA I01 BX000972NCI NIH HHS CA097274NCI NIH HHS P30 CA086862NCI NIH HHS P30CA086862NCI NIH HHS P50 CA097274NIAID NIH HHS 2P01 AI044464-2NIAID NIH HHS 5T32 AI007485NIAID NIH HHS AI057160NIAID NIH HHS P01 AI044642NIAID NIH HHS T32 AI007485NIAID NIH HHS U54 AI057160
6 · The paper itself

Abstract

Human Vγ2Vδ2 T cells monitor isoprenoid metabolism by recognizing foreign (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP), a metabolite in the 2-C-methyl-D-erythritol-4-phosphate pathway used by most eubacteria and apicomplexan parasites, and self isopentenyl pyrophosphate, a metabolite in the mevalonate pathway used by humans. Whereas microbial infections elicit prolonged expansion of memory Vγ2Vδ2 T cells, immunization with prenyl pyrophosphates or aminobisphosphonates elicit short-term Vγ2Vδ2 expansion with rapid anergy and deletion upon subsequent immunizations. We hypothesized that a live, attenuated bacterial vaccine that overproduces HMBPP would elicit long-lasting Vγ2Vδ2 T cell immunity by mimicking a natural infection. Therefore, we metabolically engineered the avirulent aroA(-) Salmonella enterica serovar Typhimurium SL7207 strain by deleting the gene for LytB (the downstream enzyme from HMBPP) and functionally complementing for this loss with genes encoding mevalonate pathway enzymes. LytB(-) Salmonella SL7207 had high HMBPP levels, infected human cells as efficiently as did the wild-type bacteria, and stimulated large ex vivo expansions of Vγ2Vδ2 T cells from human donors. Importantly, vaccination of a rhesus monkey with live lytB(-) Salmonella SL7207 stimulated a prolonged expansion of Vγ2Vδ2 T cells without significant side effects or anergy induction. These studies provide proof-of-principle that metabolic engineering can be used to derive live bacterial vaccines that boost Vγ2Vδ2 T cell immunity. Similar engineering of metabolic pathways to produce lipid Ags or B vitamin metabolite Ags could be used to derive live bacterial vaccine for other unconventional T cells that recognize nonpeptide Ags.

Indexed as

AnimalsBacterial ProteinsCell ProliferationCells, CulturedGene DeletionHumansImmunizationLymphocyte ActivationMacaca mulattaMetabolic EngineeringMetabolic Networks and PathwaysMevalonic AcidOrganophosphatesReceptors, Antigen, T-Cell, gamma-deltaSalmonella typhimuriumSalmonella Vaccines4-hydroxy-3-methyl-2-butenyl diphosphateBacterial ProteinsMevalonic AcidOrganophosphatesReceptors, Antigen, T-Cell, gamma-deltaSalmonella Vaccines

Identifiers

PMID24943221
PMCPMC4241231
OpenAlexW1617497637

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.